main content start
How do you like the content?
Content
Breast Cancer 1m 21s

Recent advances in triple-negative breast cancer (TNBC)

Downloadable slides curated by experts

Please watch the video to access Medslides

Published 11 Jul 2022
Metastatic Triple Negative Breast Cancer is still an unmet medical need. TNBC is not just ER-negative , PR-negative & Her2-Negative disease but there are 2 additional biomarkers , PDL1 status for Immunotherapy & germline BRCA status for consideration of PARP inhibitors. A new targeted treatment Sacituzumab Govitecan as recently approved treatment of Metastatic Triple Negative Breast Cancer.
germline brca mutation pdl1 triple negative breast cancer

Disclaimer: The Views/Opinions expressed and/or opinions provided in Videos and other content on MedEnrich Website are those of respective speakers. They do not purport to reflect the opinion or views of Dr.Reddy’s Laboratories Limited or its affiliates (collectively Dr.Reddy’s)in any manner whatsoever and accordingly ,Dr.Reddys does not recommend , endorse or make any representation about the veracity and appropriateness of the views ,opinions/ information on MedEnrich website. Content on MedEnrich website may discuss uses and dosage for therapeutic product that may not have been approved in by the relevant regulatory agencies in your country. Dr.Reddy’s does not support , endorse or encourage any off-label use. Please refer to approved label before prescribing.

Perks of registering with us
Access to Online/Offline Events
Personalized Content
Access to all Features
Hi, can I help?
Chat SupportX
Support Team
Hello, how can I help you today?
Please select one of the below options.

Find Information

Unable to Login or Register

Want to share feedback